Global Human Primary Cells Market Research Report 2022

Due to the COVID-19 pandemic, the global Human Primary Cells market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Human Primary Cells market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Human Primary Cells landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Epithelial Cells accounting for % of the Human Primary Cells global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Medical segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Human Primary Cells include Lonza, Thermo Fisher Scientific, Sigma-Aldrich, Cell Biologics, PromoCell GmbH, Cureline, Zen-Bio, STEMCELL Technologies and Cell Applications, etc. In terms of revenue, the global 3 largest players have a % market share of Human Primary Cells in 2021.
This report focuses on Human Primary Cells volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Human Primary Cells market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Human Primary Cells Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Epithelial Cells
Fibroblasts
Hematopoietic
Liver Cells
Mesenchymal Stem Cells
Muscle Cells
Pericytes
Segment by Application
Medical
Scientific Research
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Lonza
Thermo Fisher Scientific
Sigma-Aldrich
Cell Biologics
PromoCell GmbH
Cureline
Zen-Bio
STEMCELL Technologies
Cell Applications
Pelobiotech
Creative Bioarray
Charles River Laboratories
Axol Bioscience
ReachBio Research Labs